Technology Trends in Drug Discovery and Development: Implications for the Development of the Pharmaceutical Industry in Australia

Keywords

Section (typography), Pharmaceutical industry, Pipeline (software), Drug development, Technology development

References

• Magic bullets fly again.Carlos Saldaña Fernández — 2001
• Information Technology and the Revolution in HealthcareJohn Houghton — 2002
• R&d Costs, Innovative Output and Firm Size in the Pharmaceutical IndustryJoseph A. DiMasi, Henry G. Grabowski, John M. Vernon — 1995
• Large-scale virtual screening for discovering leads in the postgenomic eraBohdan Waszkowycz, Timothy D. Perkins, Richard A. Sykes — 2001
• High-throughput chemistry and structure-based design: survival of the smartest.David Bailey, David T. Brown — 2001
• Drug discovery: a historical perspective.Jürgen Drews — 2000
• How many leads from HTS?Roger Lahana — 1999
• Combinatorial chemistry in drug discoveryJoseph C. Hogan — 1997
• Industrial-scale, genomics-based drug design and discovery.Philip M. Dean, Edward D. Zanders, David Bailey — 2001
• The continuing evolution of the drug discovery process in the pharmaceutical industry.Emiliangelo Ratti, David G. Trist — 2001
• Blue Gene: A vision for protein science using a petaflop supercomputerFrances Allen, George Almási, Wanda Andreoni — 2001
• Scale, scope, and spillovers: the determinants of research productivity in drug discovery.Rebecca Henderson, Iain Cockburn — 1996
• Genetic information, genomic technologies, and the future of drug discovery.Thomas F. Bumol — 2001
• Innovation Deficit in the Pharmaceutical IndustryJürgen Drews, Stefan Ryser — 1996
• High‐throughput screening in natural product drug discovery in Australia utilising Australia's biodiversityRonald J. Quinn — 1999
• Innovative output and firm size in the pharmaceutical industrySamuel B. Graves, Nan S. Langowitz — 1992
• New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical FirmsJoseph A. DiMasi — 2000
• The Impact of Technological Advances on Drug Discovery TodayEsther F. Schmid, Keith James, Dennis A. Smith — 2001
• Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research.Iain Cockburn, Rebecca Henderson — 2001
• Proteomics: new perspectives, new biomedical opportunitiesRosamonde E. Banks, Michael J. Dünn, Denis F. Hochstrasser — 2000

Cited by

• Information Technology and the Revolution in HealthcareJohn Houghton — 2002
• PharmaMar: una aplicación de la teoría de opciones reales a la valoración de empresas farmaceúticasDiego Piñeiro Groba, Ángel León — 2004
• Development Paths for Australian Biomedical FirmsBruce Rasmussen, Kim Sweeny — 2002
• Implications of the Business Strategies ofPharmaceutical Companies forIndustry Developments in AustraliaBruce Rasmussen — 2002
• Marketing strategies adopted by small and medium enterprises in Nairobi central business districtMargaret J. Rugut — 2012
• A multidimensional analysis of post-acquisition performance : the case of research and development in the pharmaceutical sectorRupert Booth — 2011
• Valuation of a Biotech Company: A Real Options ApproachÁngel León, Diego Piñeiro — 2004
• DRUG DISCOVERY: AN APPRAISAL Review ArticleV. Umashankar, Sakteesh Gurunathan — 2015
• A Study on Cheminformatics and its Applications on Modern Drug DiscoveryB. Firdaus Begam, J. Satheesh Kumar — 2012
• Development of the nanotiter plate for use in antibody and cell array technologiesDevin Ramdutt, Rodney Lui, Kerrie Davies — 2005
• USE OF GENOMICS AND PROTEOMICS IN PHARMACEUTICAL DRUG DISCOVERY AND DEVELOPMENT: A REVIEWSharma Neha, S. L. Harikumar Rayat — 2013
• Marketing strategies adopted by veterinary pharmaceutical firms in Kenya to enhance performancePatrick N Munyole — 2015
• The cellular thermal shift assay : a novel strategy to study drug target engagement and resistance development in cancer therapyUsha Sreekumar Lekshmy Kunjamma — 2018
• Proteomics Applications in Health: Biomarker and Drug Discovery and Food IndustryNasrin Amiri‐Dashatan, Mehdi Koushki, Hojjat‐Allah Abbaszadeh — 2018
• THE EFFECTIVE E OF MARKETING STRATEGIES ON SALES PERFORMA CE OF PHARMACEUTICAL COMPANIES IN AIROBI, KENYAElizabeth N Lule — 2017
• Crucial Role of Nursing Profession in the Era of Genomics MedicineE. William Ebomoyi — 2018
• Biodiversity in West African Biomes and the Involvement of Traditional Healers in Bio-processing and Therapeutic Drug DevelopmentE. Ebomoyi — 2011
• FACULDADE DE CIÊNCIAS FARMACÊUTICAS Programa de Pós-Graduação em Fármaco e Medicamentos Área de Insumos FarmacêuticosSilvio Barberato Filho — 2006
• Creating and capturing value in the biopharmaceutical sectorBruce Rasmussen — 2008
• Prediction and Drug Discovery 1 GENOTOXICITY PREDICTION AND DRUG DISCOVERYChuang LavanyaPuchakayala, Juan Huang — 2011

Related papers

• Evaluation of policies to support drug development in New Zealand.Michelle Lockhart, Zaheer Ud-Din Babar, Sanjay Garg — 2010
• Accessing external innovation in drug discovery and developmentPierre Tufféry — 2015
• Effective Partnering of Academic and Physician Scientists with the Pharmaceutical Drug Development IndustryScott P. Kennedy, B. J. Bormann — 2006
• Major Issues and Trends in Drug Discovery and Development: India’s Emerging RolePankaj M. Madhani — 2007
• Natural products and drug discovery: a survey of stakeholders in industry and academiaVafa Amirkia, Michael Heinrich — 2015
• University-industry collaboration in drug discovery in Japan: An empirical analysis over thirty yearsRyo Okuyama, Hiroshi Osada — 2013
• Drug discovery in pharmaceutical industry: productivity challenges and trends.Ish Khanna — 2012
• Drug development and regulationDuncan Richards — 2003